Autologous tolerogenic dendritic cells

BIOLOGICAL3 trials

Sponsors

Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus, Fundacion Clinic per a la Recerca Biomédica

Conditions

Diabetes MellitusKidney Transplant RejectionLynch Syndrome

Phase 1

The Treatment of Patients With Type 1 Diabetes Mellitus With Autologous Tolerogenic Dendritic Cells

CompletedNCT05207995

Institute of Biophysics and Cell Engineering of National Academy of Sciences of BelarusDiabetes Mellitus

Start: 2022-03-01End: 2023-12-26Updated: 2025-12-02

Autologous Tolerogenic Dendritic Cells (ATDC) for Highly Sensitized Kidney Transplant Recipients

Not yet recruitingNCT06852625

Fundacion Clinic per a la Recerca BiomédicaKidney Transplant Rejection

Start: 2025-05-31End: 2028-03-31Target: 30Updated: 2025-02-28

First in Human Pilot Study to Assess the Safety and Efficacy of Dendritic Cells Loaded With Frameshift Derived Neopeptides for the Prevention of Cancer in of Lynch Syndrome Carriers

RecruitingNCT07163403

Fundacion Clinic per a la Recerca BiomédicaLynch Syndrome

Start: 2025-09-04End: 2028-09-20Target: 20Updated: 2025-12-04